Central nervous system (illustration): after a Covid-19 infection, the olfactory nerve cells are often exposed to an ongoing immune assault, leading to persistent anosmia (loss of smell), a new study finds.

Image source: Adobe Stock/SciePro

News • Anosmia

Loss of smell after Covid-19: Researchers find key reason

The reason some people fail to recover their sense of smell after Covid-19 is linked to an ongoing immune assault on olfactory nerve cells and an associated decline in the number of those cells, a team of scientists led by Duke Health report.

The finding, published in the journal Science Translational Medicine, provides an important insight into a vexing problem that has plagued millions who have not fully recovered their sense of smell after Covid-19. 

While focusing on the loss smell, the finding also sheds light on the possible underlying causes of other long Covid-19 symptoms – including generalized fatigue, shortness of breath, and brain fog – that might be triggered by similar biological mechanisms. “One of the first symptoms that has typically been associated with Covid-19 infection is loss of smell,” said senior author Bradley Goldstein, M.D., Ph.D., associate professor in Duke’s Department of Head and Neck Surgery and Communication Sciences and the Department of Neurobiology. “Fortunately, many people who have an altered sense of smell during the acute phase of viral infection will recover smell within the next one to two weeks, but some do not,” Goldstein said. “We need to better understand why this subset of people will go on to have persistent smell loss for months to years after being infected with SARS-CoV-2.”

We are hopeful that modulating the abnormal immune response or repair processes within the nose of these patients could help to at least partially restore a sense of smell

Bradley Goldstein

In the study, Goldstein and colleagues at Duke, Harvard and the University of California-San Diego analyzed olfactory epithelial samples collected from 24 biopsies, including nine patients suffering from long-term smell loss following Covid-19. This biopsy-based approach -- using sophisticated single-cell analyses in collaboration with Sandeep Datta, M.D., Ph.D., at Harvard University -- revealed widespread infiltration of T-cells engaged in an inflammatory response in the olfactory epithelium, the tissue in the nose where smell nerve cells are located. This unique inflammation process persisted despite the absence of detectable SARS-CoV-2 levels. 

Additionally, the number of olfactory sensory neurons were diminished, possibly due to damage of the delicate tissue from the ongoing inflammation. “The findings are striking,” Goldstein said. “It’s almost resembling a sort of autoimmune-like process in the nose.” 

Goldstein said learning what sites are damaged and what cell types are involved is a key step toward beginning to design treatments. He said the researchers were encouraged that neurons appeared to maintain some ability to repair even after the long-term immune onslaught. “We are hopeful that modulating the abnormal immune response or repair processes within the nose of these patients could help to at least partially restore a sense of smell,” Goldstein said, noting this work is currently underway in his lab. He said the findings from this study could also inform additional research into other long-Covid-19 symptoms that might be undergoing similar inflammatory processes. 

In addition to Goldstein and Datta, study authors include John B. Finlay, David H. Brann, Ralph Abi-Hachem, David W. Jang, Allison D. Oliva, Tiffany Ko, Rupali Gupta, Sebastian A. Wellford, E. Ashley Moseman, Sophie S. Jang, Carol H. Yan, Hiroaki Matusnami, and Tatsuya Tsukahara. 


Source: Duke University Health System

28.12.2022

Read all latest stories

Related articles

Photo

News • Disrupted neurogenesis

Covid-19 delirium: new study reveals possible brain mechanisms

Researchers have shown that when brain cells are directly exposed to blood taken from Covid-19 patients with delirium, there is an increase in cell death and a decrease in the generation of new brain…

Photo

News • First on site, but short-lived

New insights into immune defence may explain Covid-19 reinfections

A new study has found that antibodies produced in the nose decline nine months after Covid-19 infection, while antibodies found in the blood last at least a year.

Photo

News • Answer to SARS-CoV-2 mutations

One step closer to 'variant-proof' Covid-19 vaccine

A vaccine design approach that could protect against new variants of SARS-CoV-2 but also potentially protects against other coronaviruses is one step closer to reality as a result of new research.

Related products

Alphenix Biplane High Definition Detector

Bi-Plane

Canon · Alphenix Biplane High Definition Detector

Canon Medical Systems Europe B.V.
Beckman Coulter – Access Procalcitonin (PCT)

Immunoassays

Beckman Coulter – Access Procalcitonin (PCT)

Beckman Coulter Diagnostics
Fujifilm Wako – μTASWako i30

Immunoassays

Fujifilm Wako – μTASWako i30

FUJIFILM Wako Chemicals Europe GmbH
Subscribe to Newsletter